Combining PARP inhibitor with TACC3 inhibition overcomes PARP inhibitor resistance in ovarian cancer

被引：0
|
作者：
Wu, Yu
Wang, Qilong
Deng, Chaolin
Li, Mo
Xiao, Yinan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4757
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4757
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] TACC3 deregulates the DNA damage response and confers sensitivity to radiation and PARP inhibition
    Ha, G-H
    Kim, J-L
    Petersson, A.
    Oh, S.
    Denning, M. F.
    Patel, T.
    Breuer, E-K
    ONCOGENE, 2015, 34 (13) : 1667 - 1678
  • [22] Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?
    Ray-Coquard, Isabelle
    Vanacker, Helene
    Le Saux, Olivia
    Tredan, Olivier
    EBIOMEDICINE, 2020, 61
  • [23] TACC3 deregulates the DNA damage response and confers sensitivity to radiation and PARP inhibition
    G-H Ha
    J-L Kim
    A Petersson
    S Oh
    M F Denning
    T Patel
    E-K Breuer
    Oncogene, 2015, 34 : 1667 - 1678
  • [24] PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probes
    Yu, Tony
    Lok, Benjamin H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024,
  • [25] PLK1 and PARP positively correlate in Middle Eastern breast cancer and their combined inhibition overcomes PARP inhibitor resistance in triple negative breast cancer
    Siraj, Abdul K.
    Poyil, Pratheesh Kumar
    Padmaja, Divya
    Parvathareddy, Sandeep Kumar
    Alobaisi, Khadija
    Thangavel, Saravanan
    Diaz, Roxanne
    Begum, Rafia
    Almalik, Osama
    Al-Dayel, Fouad
    Al-Kuraya, Khawla S.
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [26] Inhibition of homologous recombination, PARP inhibitor, or dianhydrodulcitol overcomes temozolomide-resistance in glioma cells
    Ohba, Shigeo
    Hirose, Yuichi
    CANCER RESEARCH, 2019, 79 (13)
  • [27] PARP inhibitor resistance in prostate cancer.
    D'Andrea, Alan D.
    CANCER RESEARCH, 2018, 78 (16) : 20 - 21
  • [28] RRM2 inhibition synergizes with PARP inhibitor in ovarian cancer cells
    Chen, Chi-Wei
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Bromodomain inhibition in ovarian cancer and the tumor microenvironment to improve PARP inhibitor response
    Wilson, Andrew J.
    Hoover, Alyssa
    Harris, Whitney
    Liu, Esther
    Khabele, Dineo
    Yull, Fiona
    CANCER RESEARCH, 2018, 78 (13)
  • [30] Tackling PARP inhibitor resistance
    Fugger, Kasper
    Hewitt, Graeme
    West, Stephen C.
    Boulton, Simon J.
    TRENDS IN CANCER, 2021, 7 (12): : 1102 - 1118
12345